glp-1 mean Frontiers A) Half-life extension mechanisms of

Its just a little easier to fit into their busy life. How those hopes play out in reality now that the FDA has given its green light remains to be seen

Robbins says

These changes may attenuate systemic autoimmunity and indirectly influence thyroid-specific immune responses

Given the results from recent studies, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend that patients with T2D and clinical cardiovascular disease (CVD) with inadequate glucose control despite treatment with metformin should receive an SGLT2 inhibitor or GLP-1 receptor agonist

Nishizawa M, Nakabayashi H, Uchida K, Nakagawa A, Niijima A

I'd love to hear your experience